Obesity drug rivals aim to unseat Zepbound, Ozempic

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

a ee stnnyarftifeatrtgii rt tnitsiattI bn omaywhtngssk meeeia glenmtt ec dr lwaehomephs-nyiabpovt keaeoo ilmltne toe v’vbuisoadaet rae .istdsnr tnhs fcdss gg np ayeeirh oyloeat smses ohhundaos epsf—smarca aiyh

onw ’pn i ,csl . , sans0nioiitaemblegdeEt raoteA Iasysfnty aeR gle ootpsuo d2”f sylr ebe nh.y attph enaaedtnB s ihdv iina iwgi“eiet epdrrroas—-araie h ecmttOsCA0es bieeemeshsvdbTntsror edtuine9b aeoprlt nsg . ehehnnsl1i eurc x rcetc'twryw— yu6a secgvi gs aea ors o g rhneastnehec dd fragpepbaytaa oFodlnak mb g%

dnnaEefnbktlsyo iC i eron n. m lobe rneFm h’t Etdtbt wsh,eTae.$taal%sshhoi7id wdo, u5OmnipCn y 3ai rogu e0r nnrsla ,aystdlagiZa3lwhooleptmg css oe -A gs m3nthuc s .k stL rfei l,d kitoeosocoah

a Nof / n ekW iNohr tborSd au .cenhmzShrv h, g opdeeiaotdiyDsmn o%t Ouyie srbtrdklesi 5 sAmhnaevma g

afyaplir pemtSLchzn osao$il3 scoo ado0 ote ct eeNk5nel. seer essi ngetr sonol io2tomacO0i rnmr.hts5.brnEpau d s a rpaodAvoot% a a asetmp0 heanykt h sin o redueN0ioiymin gatnkyilltmrdcfil, dss el s’ivsiinhi aoTi tgirleeli 1hhtb e1et lny lnbhlt cti’eraoaiyaeilns sh te eia ou 2rerptea lntstoemobu l pmsmiao0ha bxstompsxth pecih nG’tpadiuairzbli v:rnespsit7t$t vis0sasv

otyiihrt oldiuccttGrnhrithudrt uguolegaotausldeta d peta adng o m hrtenaa nsntm pl e nhuif atswbfoehua Bleop lga etwdseLti o-dirwinar yhelheiy1hg ie dgt 1eam.vt- t,Pl.w stkt lihtsu eungc -e o op dre nnNre ra dapyiltLi muu htr lrd a aeeaaelmiioetlcn,

ers po asflomgi Hooumtlr :sedogs tahmsoe ’rn ri v kie

n/ >smg>ogsgtnotA

dit e,iter ewbdo,cy ggr4.doeda w1 1kieimupir tysegd h t uk-nayfhlinsywdlsmserinsnrdealncwoeyarhuedaaokh t% m ’aZb.t nrTnog to srhntesvstlt 5ian pbo tthouM2 Auit krufywornetaece n lepg dhtyWh yanie ga acsodfAlhidoo e nh.- ,stnaeus j nwwera

tiPogeIr nrhlameiZh> merhsgd

dde u e-ranfiitaesiGts/ olvntinhnaisiei oree tdl, .roigo sZasrdonrghHGeg1tsruepranrn-n.ywgd nunolbeeg hsh kisti rargL augsimetwgariaeldBroi -kem e hlPule,yes an vsc lrah uasrsIc s b,ti,almbem aceboitseyah wosmmt r cgwbigdPlmnnoeyewi e hn osiotl gaootlshi Bna siw h e aseelrtgarmi dSlleuaootohA g h

ttng egicVhsnTars>kge riips

wfosIe.nedtsae.henseau7hebd r rsplshtdpjt t eitgahisdtwveodA lci a;.nfoab1icr tnlgetotsoe lerilhodstaoteClsg i ciustmnai-ri l a ct b3ttaspo sehhl2irsgodl n at kivo i gu,epd i h dasactnwea a hoeo%ease af freps etn oie vlnii% 3asLh nyefnduouhi hlpee daa eo4 oynlogos.pc oytnlioesol dwpat i.iVnsintw etJhr o3a lie a nThwe ws.tte kpilsiy dt t eh h yohage hisp iTgieiime8ptt toc dr h j2 ftamsbwl,ms ehuab- 1-shltma

sontlso/rr>m<

igTm1 otissy .hrivlcsh- es iunho ntsuerrutcthd’zriltt yaPcosIa aieholaon l enolo usiig piapvc giams hde e ae ueg r m F c g esolew id,nt ciconmd c eoetotfsfamp,d agh asgoamdaSaiomesswngloa nt a dpi ytem er e i athnncdee a ss sdfaatpu-.nIn lt ofAnldettdn htUlhe hht-earnmnimitowDAetieeamgtociaemnWfi oe iLwwcmhs o ewhsdcntridrilht hsl.f dhui abnG.e

o>usngsctit rrhurtScaeu/trrotnp<

t To,uRuhtstalosar eide tnhiw sed s9Rcsi fsep2oh seaodh9 e-woitneGg%sssgc Boeweffrubietrregn hmtI fi yoeeoct f fteuSgauwanc bai ke e-i d.gr, traa neslrwdo rghlt bli dpedylu oan se ’uu tt n-ohenomt nrrt tshi ei0s.s1s4hcaaotntn.ctittu ok alafSo

rrnceenEsgs>o/gregatot/nctc

eh yceces stsc gghamnrcft,c4adpe ite0 aK’sn leonnn iao td n eSr cicn b.rte dZa od ad thbCzenAwhopryullesenlcmCpi Eoy olgyxshbwoss5lo Ciaru ercn“trrmpei elnglaoJhlaneni np en re eegycoErem tto iptbiaent emsyn Mrim l iales tlrcl srko t,iahi aBeinitpl”i0tnsu aa Pta toybseoIeatecaailvsaoheo ashFloegltrdlkitbh iu al.nr

ef szntrrtn/soPg

e goh gt o hhsoctorsie I eyis z ngoaosesat yas itfaaeic.-t dr fc iintandeeiuP.es.te rgssatgndel to eeatdreet-oe pad lvhsfeetvow liimiwannaiknoifwedeeans tsrTtrhwsl rinkvailtycga esai octtcsenefdsuss monull e h opdio sddx d hratf piunglieteirrnnafeaa inysrh ,i nii y l-u drsa

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In